Form 4: Teladoc Health Executive Arnnon Geshuri Reports Stock Transactions
SEC Form 4
Arnnon Geshuri, Chief People Officer of Teladoc Health, reports the acquisition and disposal of Teladoc Health common stock and derivative securities.
Summary
- On May 31, 2024, Arnnon Geshuri, the Chief People Officer of Teladoc Health, engaged in transactions involving Teladoc Health's common stock and derivative securities.
- These transactions included the conversion of performance stock units and restricted stock units into common stock.
- Geshuri also sold 1,807 shares of common stock on June 3, 2024, at a price of $11.157 per share to cover tax withholding obligations related to the vesting of performance stock units and restricted stock units.
- Following these transactions, Geshuri directly owns 41,686 shares of Teladoc Health common stock and holds derivative securities including 6,842 performance stock units, 3,538 restricted stock units from a 2022 grant, and 20,075 restricted stock units from a 2023 grant.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Comparison to Industry Standards
- Executive stock transactions are a normal part of compensation and wealth management in publicly traded companies.
- Similar filings are made by executives at companies like Amwell (AMWL) and Accolade (ACCD), reflecting their individual investment strategies and compensation structures.
- The vesting schedules and types of equity awards (RSUs, PSUs) are also standard practices across the industry to align executive incentives with company performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
- Employees may be interested in the stock transactions of the Chief People Officer.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| March 3, 2023 | Reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| March 1, 2024 | The reporting person earned 11,728 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| May 31, 2024 | Transactions involving conversion of performance stock units and restricted stock units to common stock. |
| June 3, 2024 | 1,807 shares sold at $11.157 per share to cover tax obligations. |
| June 4, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.